Adjuvant Aspirin: Big Benefits for Some CRC Patients

Dr. David Kerr reports on a study providing more evidence that patients with PIK3CA-mutant colorectal cancer benefit most from adjuvant aspirin therapy, but awaits prospective trials for confirmation.

Source: Medscape Pharmacists Podcast - January 27, 2014 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts